You can’t blame your brain for your actions!
Neuroscientists at HSE University have challenged the famous studies that question the free will of our decisions. You can’t shift responsibility for your actions to the brain. The results of the new work were recently published in the journal Neuropsychologia.
Historical Context of the Free Will Debate
The dispute about how much free will people have in making their decisions has been going on for decades. Neuroscientists have joined this discussion thanks to the electroencephalographic (EEG) experiments of Benjamin Libet. In the 1970-1980s, he showed that 0.5–1.5 seconds before conscious awareness of the intention to perform a movement, subjects emit EEG activity that predicts this movement. It turns out that the brain makes a decision and sends readiness potential before a person realizes it, and our actions are nothing more than the result of an unconscious physiological process in the brain.
The results of Libet’s experiments have generated a lot of controversy about free will, and some neurophysiologists have even concluded that it does not exist. Moreover, Libet’s experiment has been repeated using functional magnetic resonance imaging, and it turns out that the decision of the subject can be predicted even 6-10 seconds before their conscious awareness of it.
HSE University’s Take on the Paradigm
The staff of the HSE Institute for Cognitive Neuroscience questioned this experimental paradigm and in their new study confirmed that the time of intention awareness in Libet’s experiments was determined incorrectly. In addition, EEG activity, or the brain signal indicating the readiness of a decision, which was recorded by Benjamin Libet before the decision was made, actually has no direct link to this decision.
In the Libet’s original experiment, the subjects were asked to occasionally bend their wrists and at the same time remember the moment when they felt ready to perform this action. The time of intention awareness was recorded from the words of the subjects themselves: they observed a point that moved along the screen dial, similar to a clock hand, and indicated the position of the point when they felt the desire to bend their hand. The moment of the final decision was determined by the exact reading of the sensor attached to the wrist of the subjects.
The HSE neuroscientists repeated the experiment with two groups of subjects, adding small changes to the task in one of the groups. Using behavioral reports and hypersensitive EEG techniques, the scientists investigated the correlation between the time of intention awareness and the time of final decision. It turned out that the time of awareness can be influenced by experimental procedures: for example, without certain training, the subjects are barely able to determine their intentions, and the traditional Libet paradigm pushes them to the feeling that they can determine the moment of decision-making and intention. Apparently, the instruction itself in the Libet task makes the participants feel that the intention should emerge long before the final decision is made.
In addition, the study confirmed that there is no direct link between the activity of the brain preceding the action and the intention to perform the action. The sense of intention emerged in the subjects at different points in time, whereas the readiness potential was always registered at about the same time. Thus, the readiness potential may reflect the general dynamics of the decision-making process about making a move, but it does not mean that the intention to act has already been generated.
Concluding Thoughts
“Our study highlights the ambiguity of Libet’s research and proves the absence of a direct correlation between the brain signal and decision-making. It appears that the classical Libet paradigm is not suitable for answering the question of whether we have free will while making decisions. We need to come up with a new approach to this extremely interesting scientific puzzle,” says Dmitry Bredikhin, author of the research and junior Research Fellow at the Centre for Cognition & Decision Making.
“Neuroscience tries to answer key questions in our life, including questions of free will and responsibility for our actions. We need to be especially precise in order to draw conclusions that affect our outlook and attitude toward life. Therefore, we tried to understand the predetermination of our decisions and confirmed a number of shortcomings in the famous experiments of Benjamin Libet. This does not mean that we have closed this issue of the illusory nature of our free will, but rather emphasizes that the discussion continues. This might be one of the most interesting questions in modern science, to which we have yet to give a definitive answer,” comments Vasily Klucharev, Project coordinator and leading Research Fellow of the Institute for Cognitive Neuroscience.
Reference: “(Non)-experiencing the intention to move: On the comparisons between the Readiness Potential onset and Libet’s W-time” by Dimitri Bredikhin, Ksenia Germanova, Vadim Nikulin and Vasily Klucharev, 29 April 2023, Neuropsychologia.
DOI: 10.1016/j.neuropsychologia.2023.108570
News
Scientists Have Uncovered Previously Hidden Microbial Activity on Human Skin
The most abundant microbes on your skin may not be the ones doing most of the work. Human skin supports vast communities of bacteria, fungi, and viruses that can influence its protective barrier, immune [...]
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]















